Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing sudden cardiac death.

M H Lehmann1, R T Steinman

  • 1Division of Cardiology, Harper Hospital, Detroit, MI 48201.

Postgraduate Medicine
|November 15, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotactic activity of serum obtained from patients with idiopathic dilated cardiomyopathy.

Die Pharmazie·2006
Same author

Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications.

Journal of the American College of Cardiology·2001
Same author

Sexual dimorphism in the electrocardiographic dynamics of human ventricular repolarization: characterization in true time domain.

Circulation·2001
Same author

Constitutive expression of MCP-1 and RANTES in the human histiocytic lymphoma cell line U-937.

Immunology letters·2001
Same author

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Circulation·2001
Same author

Angiotensin II type 1 receptor gene polymorphism is associated with the severity but not prevalence of coronary artery disease.

Clinical genetics·2000
Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
See all related articles

Sudden cardiac death, often caused by ventricular arrhythmias, can be prevented. Electrophysiologic testing assesses antiarrhythmic drugs, and implantable cardioverter-defibrillators offer protection for unresponsive patients.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology

Background:

  • Sudden cardiac death (SCD) is a major cause of mortality in the US, frequently resulting from ventricular tachycardia or fibrillation.
  • Current management strategies aim to prevent recurrence in survivors.

Purpose of the Study:

  • To outline the role of electrophysiologic testing in preventing recurrent sudden cardiac death.
  • To discuss therapeutic options for patients with medically unresponsive ventricular tachyarrhythmias.

Main Methods:

  • Electrophysiologic testing to assess the efficacy of antiarrhythmic drugs in preventing induced sustained ventricular tachyarrhythmias.
  • Evaluation of implantable cardioverter-defibrillators (ICDs) for patients unresponsive to drug therapy.

Main Results:

Related Experiment Videos

  • Electrophysiologic testing provides a method to evaluate antiarrhythmic drug efficacy beyond merely suppressing premature beats.
  • ICDs offer a high level of protection against sudden cardiac death in selected patients.

Conclusions:

  • Electrophysiologic testing is a valuable tool for guiding antiarrhythmic therapy to prevent life-threatening ventricular arrhythmias.
  • Implantable cardioverter-defibrillators represent a crucial option for managing patients at high risk of sudden cardiac death.